Intact Genomics is excited to announce its participation in the 17th Annual Next Generation Dx Summit, taking place in Washington, D.C., on August 18–20, 2025. The Next Generation Dx Summit is the nexus for international thought leaders to discuss diagnostic advancement and technology innovation. This year’s event provides a valuable window on the state-of-the-art, forecasting, and future trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, regulation, and companion diagnostics to improve the standard of care in medicine.
“Intact Genomics is a leading biotechnology firm specializing in isothermal DNA/RNA amplification, PCR, RT-qPCR, large DNA fragment cloning, and direct capture,” said Dr. Chengcang Charles Wu, the company’s CEO. “We are committed to providing high-quality products and services for the next generation of diagnostic solutions.”
Intact Genomics will have a poster presentation. Click here to download our poster “Innovative FastAmp® Viral and Cell Lysis Solution Enables Simple RPA-based PoC Diagnostics and Nucleic Acids Testing of Viral Pathogens”.